Literature DB >> 16494848

Regulation of matrilysin expression in endothelium by fibroblast growth factor-2.

Wolfgang Holnthoner1, Marc Kerenyi, Marion Gröger, Franz Kratochvill, Peter Petzelbauer.   

Abstract

Matrilysin (MMP7) is a secreted matrix metalloproteinase, which contributes to angiogenesis by breaking down basement membranes. We show that the angiogenic factor FGF-2 induces MMP7 expression in human endothelial cells. The promoter contains a Lef/Tcf consensus sequence, but using wildtype or Lef/Tcf-mutated promoter constructs, FGF-2-induced MMP7 reporter activity is independent from Lef/Tcf sites. Instead, we show that overexpression of a dominant negative Stat3 mutant reduces FGF-2-mediated MMP7 promoter activity. However, Stat3 does not bind to the MMP7 promoter, but activates MMP7 gene expression indirectly via AP-1. This is confirmed by MMP7 promoter constructs with mutated AP-1 sites which did not respond to FGF-2 and by siRNAs against Stat1 and Stat3, which repressed FGF-2-induced MMP7 protein expression. In conclusion, we show that FGF-2-induced MMP7 expression in endothelium depends on AP-1 and FGF-2 signaling to AP-1 involves a Stat1/3-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494848     DOI: 10.1016/j.bbrc.2006.02.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors.

Authors:  Wiem Lassoued; Danielle Murphy; Jeff Tsai; Ridha Oueslati; Gavin Thurston; William M F Lee
Journal:  Cancer Biol Ther       Date:  2010-12-15       Impact factor: 4.742

2.  Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.

Authors:  Mohamed Izikki; Christophe Guignabert; Elie Fadel; Marc Humbert; Ly Tu; Patricia Zadigue; Philippe Dartevelle; Gerald Simonneau; Serge Adnot; Bernard Maitre; Bernadette Raffestin; Saadia Eddahibi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

3.  Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer.

Authors:  Ming Shi; Dan Liu; Huijun Duan; Caili Han; Bo Wei; Lu Qian; Changguo Chen; Liang Guo; Meiru Hu; Ming Yu; Lun Song; Beifen Shen; Ning Guo
Journal:  Mol Cancer       Date:  2010-10-12       Impact factor: 27.401

4.  The transcription factor SOX18 regulates the expression of matrix metalloproteinase 7 and guidance molecules in human endothelial cells.

Authors:  Martina Hoeth; Heide Niederleithner; Renate Hofer-Warbinek; Martin Bilban; Herbert Mayer; Ulrike Resch; Christof Lemberger; Oswald Wagner; Erhard Hofer; Peter Petzelbauer; Rainer de Martin
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 5.  Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability.

Authors:  Jean Marie Ruddy; John S Ikonomidis; Jeffrey A Jones
Journal:  J Vasc Res       Date:  2016-06-22       Impact factor: 1.934

6.  Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model.

Authors:  Fanrui Meng; Yukai Cao; Han Su; Tianyan Liu; Limin Tian; Yu Zhang; Jiarui Yang; Wei Xiao; Deshan Li
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

Review 7.  Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review.

Authors:  Sabeena Mustafa; Sheeja Koran; Lamya AlOmair
Journal:  Front Mol Biosci       Date:  2022-09-29

8.  Expression profiling of human glial precursors.

Authors:  James T Campanelli; Robert W Sandrock; Will Wheatley; Haipeng Xue; Jianhua Zheng; Feng Liang; Jonathan D Chesnut; Ming Zhan; Mahendra S Rao; Ying Liu
Journal:  BMC Dev Biol       Date:  2008-10-23       Impact factor: 1.978

9.  Stage and tissue-specific prognostic impact of miR-182 in NSCLC.

Authors:  Helge Stenvold; Tom Donnem; Sigve Andersen; Samer Al-Saad; Lill-Tove Busund; Roy M Bremnes
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.